TuHURA Biosciences, DOR, Delta Opioid Receptor, Antibody Drug Conjugate, ADC, Cancer Immunotherapy, Immuno-Oncology, MDSCs, Myeloid-Derived Suppressor Cells

Tampa, Florida, U.S., October 5, 2026 TuHURA Biosciences, Inc. has announced that the U.S. Patent and Trademark Office (USPTO)...